A Safety and Efficacy Study for Alzheimer's Disease (Prodromal AD)
- Registry ID
- EUCTR2012-005542-38
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE3
- Sponsor
- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,
- Start date
- 2014-02-12
- Completion date
- 2018-04-17
- Last update
- 2026-08-16
Conditions
- prodromal Alzheimer's Disease
Summary
• To assess the efficacy of two doses of MK-8931 based on overall clinical progression in subjects with prodromal Alzheimer's Disease (AD).
• To assess the safety and tolerability of two doses of MK-8931 in the treatment of subjects with prodromal AD.
Locations
- , , Spain
- , , Germany
- , , UK
- , , Netherlands
- , , Hungary
- , , Austria
- , , Belgium
- , , Poland
- , , Finland
- , , Italy
- , , Norway
View on source registry